The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria

The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria

<p>Abstract</p> <p>Background</p> <p>This study aimed to determine the therapeutic effects of highly active anti-retroviral therapy (HAART) on the clinical presentations of HIV related oral lesions (HIV-ROLs) in an adult Nigerian population.</p> <p>Methods&l...

Full description

Bibliographic Details
Main Authors:	Hassan Zuwaira, Taiwo Olaniyi O
Format:	Article
Language:	English
Published:	BMC 2010-06-01
Series:	AIDS Research and Therapy
Online Access:	http://www.aidsrestherapy.com/content/7/1/19

Similar Items

HIV-related oral lesions in patients on HAART: A preliminary study in Enugu, Southeast Nigeria
by: Ezi A Akaji, et al.
Published: (2020-01-01)

Tolerability of antiretroviral therapy (HAART) in elderly age
by: Celesia B M
Published: (2010-05-01)

Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
by: Arif Alibhai, et al.
Published: (2010-04-01)

Impact of highly active antiretroviral therapy (HAART) on clinical outcomes of vertically HIV-1 infected children
by: Muñoz-Fernandez MªÁngeles, et al.
Published: (2008-04-01)

Kepatuhan pesakit HIV positif terhadap rawatan Highly Active Antiretroviral Therapy (HAART)
by: Najwa Afiqa Roshaizad,, et al.
Published: (2020)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
by: N. Sunil Kumar, et al.
Published: (2015-07-01)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia
by: Hejazi, Nazisa, et al.
Published: (2014)

Considering childbearing in the age of highly active antiretroviral therapy (HAART): Views of HIV-positive couples
by: Vezumuzi Ndlovu
Published: (2009-09-01)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
by: M Neeraja, et al.
Published: (2020-01-01)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
by: Kutamba Elizabeth, et al.
Published: (2010-05-01)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

The effects of gender on clinical and immunological response to antiretroviral therapy among people living with HIV in Ile-Ife, Nigeria
by: Olaniyi E. Onayemi, et al.
Published: (2018-11-01)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
by: Palermo F, et al.
Published: (2010-05-01)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
by: Leona Dold, et al.
Published: (2015-01-01)

Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy)
by: Farmer Paul, et al.
Published: (2001-01-01)

Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients
by: Hamilton Domingos, et al.

Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria
by: Paul Columba Inyang-Etoh, et al.
Published: (2018-01-01)

Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses
by: Paul L. Fidel, et al.
Published: (2021-04-01)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
by: Dereudre-Bosquet Nathalie, et al.
Published: (2009-09-01)

Effectiveness of antiretroviral therapy (haart) In hiv positive patients admitted to the treatment Program of “atencion integral ips” in the city of Cartagena. Colombia
by: Torres-Mora Gustavo, et al.
Published: (2011-06-01)

HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration
by: Henry David, et al.
Published: (2010-10-01)

HIV/HCV coinfection, HAART, and liver-related mortality.
by: Sabin, C, et al.
Published: (2004)

Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.
by: Jose Manuel Vazquez-Guillen, et al.
Published: (2016-01-01)

The impact of HIV-1 subtype on the clinical response on HAART.
by: Frater, J
Published: (2002)

At the helm of haart: The experience of biographical time among people living with hiv in Nigeria
by: Ayodeji Bayo Ogunrotifa
Published: (2021-01-01)

Strategies for improving pediatric/adolescent HIV suppression rates for patients on HAART in Nigeria
by: A.V. Enejoh, et al.
Published: (2016-08-01)

Determinants of response to first HAART regimen in antiretroviral-naive patients with an estimated time since HIV seroconversion.
by: Thiébaut, R, et al.
Published: (2006)

Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART) - naïve patients
by: Akinsegun Akinbami, et al.
Published: (2012-07-01)

Association of oral candidal carriage, candidal density and CD4 count among normal, HIV patients with HAART and without HAART
by: Shahabe Saquib Abullais, et al.
Published: (2022-06-01)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
by: Sinha Rajesh, et al.
Published: (2008-01-01)

Hybrid data capture for monitoring patients on highly active antiretroviral therapy (HAART) in urban Botswana
by: Bussmann Hermann, et al.
Published: (2006-01-01)

Ocular problems in brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era
by: Marcia Lopes Rodrigues, et al.

Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al.

Changes in liver function test levels in HIV patients undergoing highly active antiretroviral therapy (HAART). Longitudinal study in Lima, Peru
by: Jeel Moya-Salazar, et al.
Published: (2021-05-01)

Estimating the cost to rural ambulating HIV/AIDS patients on Highly Active Antiretroviral Therapy (HAART) in rural Ghana: a pilot study
by: Stephen Apanga, et al.
Published: (2012-06-01)

60PV Related Lesions in HIV Positive Subjects on HAART: Study of Viral Markers of Cervical Neoplasia Progression
by: Lazzarin Adriano, et al.
Published: (2005-12-01)

Penggunaan Highly Active Antiretroviral Theraphy (HAART) Terhadap Health Related Quality of Life (HRQOL) pada Orang Dengan HIV/AIDS
by: Angga Wilandika
Published: (2018-12-01)

Assessment of oral mucosal lesions among HIV positive transgenders residing in Odisha with and without Antiretroviral therapy
by: Shilpa Rai, et al.
Published: (2022-01-01)

Drug-Resistant HIV-1 RT Gene Mutations in Patients under Treatment with Antiretroviral Drugs (HAART) in Iran
by: Gol Mohammadi, R, et al.
Published: (2015-04-01)